EODData

FRA, CN2: Catalyst Pharmaceuticals Inc

21 Nov 2025
LAST:

19.51

CHANGE:
 0.13
OPEN:
19.51
HIGH:
19.51
ASK:
0.00
VOLUME:
685
CHG(%):
0.67
PREV:
19.38
LOW:
19.51
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 Nov 2519.5119.5119.5119.51685
20 Nov 2519.3819.3819.3819.38685
19 Nov 2519.2719.2719.2719.27685
18 Nov 2519.0719.0719.0719.07685
17 Nov 2519.5719.5719.5719.57685
13 Nov 2519.4219.4219.4219.42685
12 Nov 2519.6819.6819.6819.68685
11 Nov 2518.3118.3118.3118.31685
10 Nov 2518.2718.5418.2718.54685
07 Nov 2517.9618.2417.9517.982.5K

PROFILE

Name:Catalyst Pharmaceuticals Inc
About:Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); Fycompa, a novel non-competitive selective antagonist at the postsynaptic ionotropic alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid glutamate receptor that is used to treat focal onset seizures, as well as tonic-clonic seizures; Ruzurgi for the treatment of pediatric LEMS patients; and AGAMREE, a corticosteroid for the treatment of duchenne muscular dystrophy. The company has license agreements with BioMarin Pharmaceutical Inc.; and a collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.
Sector:Healthcare
Industry:Biotechnology
Address:355 Alhambra Circle, Coral Gables, FL, United States, 33134
Website:https://catalystpharma.com
ISIN:US14888U1016
LEI:5299004O0R5XXLA5H544

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:13.07 
Forward P/E:33.98 
PEG Ratio:0.57 
Price to Sales:4.25 
Price to Book:2.67 
Profit Margin:0.37 
Operating Margin:0.45 
Return on Assets:0.18 
Return on Equity:0.28 
Revenue:484.72M 
EBITDA:237.0M 
Shares:122.39M 
Market Cap:2.387B 

TECHNICAL INDICATORS

MA5:19.360.8%
MA10:19.072.3%
MA20:18.674.5%
MA50:17.899.0%
MA100:17.789.7%
MA200:19.241.4%
STO9:87.59 
STO14:76.25
RSI14:60.45 
WPR14:-23.75
MTM14:0.82
ROC14:0.04 
ATR:0.63 
Week High:19.570.3%
Week Low:19.072.3%
Month High:19.982.4%
Month Low:17.641.4%
Year High:23.8622.3%
Year Low:16.1520.8%